The Incidence Decay and Exponential Adjustment (IDEA) model: a new single equation model to describe epidemics and their simultaneous control.

Similar documents
Module 5: Introduction to Stochastic Epidemic Models with Inference

Module 5: Introduction to Stochastic Epidemic Models with Inference

1) Complete the Table: # with Flu

Detailed Parameters of the BARDA Interactive Flu Model

SARS Outbreaks in Ontario, Hong Kong and Singapore

arxiv: v1 [stat.ap] 3 Mar 2016

Mathematical Modeling of Infectious Diseases

Mathematical Modeling of Infectious Disease

Infectious disease modeling

The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission

Background Describing epidemics Modelling epidemics Predicting epidemics Manipulating epidemics

Contents. Mathematical Epidemiology 1 F. Brauer, P. van den Driessche and J. Wu, editors. Part I Introduction and General Framework

Type and quantity of data needed for an early estimate of transmissibility when an infectious disease emerges

WHAT S INFECTIOUS and HOT: 2014

Case Studies in Ecology and Evolution. 10 The population biology of infectious disease

Preventing disease Promoting and protecting health

MERS H7N9. coronavirus. influenza virus. MERS: Since September 2012: 160 cases, including 68 deaths (42%)

Mathematical Modelling of Effectiveness of H1N1

Part I Infection Risk

10/29/2014. Influenza Surveillance and Reporting. Outline

School of Health Sciences PBHE 605 Quarantine 3 Credit Hours Length of Course: 8 weeks Prerequisite: None

Viruses: Select Agents and Emerging Pathogens. Patricia Bolívar MS., CLS, PHM

Introduction to Reproduction number estimation and disease modeling

Of Camels, Bats and Coronaviruses: the (beginning of the) story of MERS-CoV

Network Science: Principles and Applications

Introduction to Infectious Disease Modelling and its Applications

Middle East Respiratory Syndrome Coronavirus

INFLUENZA SURVEILLANCE

Cough, Cough, Sneeze, Wheeze: Update on Respiratory Disease

Religious Festivals and Influenza. Hong Kong (SAR) China. *Correspondence to:

S evere acute respiratory syndrome (SARS), a contagious

IS THE UK WELL PREPARED FOR A REPEAT OF THE 1918 INFLUENZA PANDEMIC?

Marc Baguelin 1,2. 1 Public Health England 2 London School of Hygiene & Tropical Medicine

Global Health Security: Preparedness and Response: can we do better and stay safe?

Case study: Epidemic modelling in real life

Timing of vaccination campaigns against pandemic influenza in a population dynamical model of Vancouver, Canada

BC MHOs, PHNLs, ICPs, ERDOCs, IDSPEC, MEDMICRO, AMBULANCE, BCCDC Internal Groups, National Surveillance Network Partners

The Economics of Zoonotic Diseases in China

UPDATE ON INFECTIOUS DISEASES 2015

Occupational Infections: Risks for the Anesthesiologist

NC IMMUNIZATION COALITION FLU THEN AND NOW NC DHHS COMMUNICABLE DISEASE BRANCH ANITA VALIANI, MPH AUGUST 1, 2018

The mathematics of diseases

Follow links Class Use and other Permissions. For more information, send to:

Experiences on Workforce Development in Other Regions

MERS. G Blackburn DO, MACOI Clinical Professor of Medicine MSUCOM

MI Flu Focus. Influenza Surveillance Updates Bureaus of Epidemiology and Laboratories

Mathematics of Infectious Diseases

Strategies for containing an emerging influenza pandemic in South East Asia 1

How Math (and Vaccines) Keep You Safe From the Flu

The Triple Axel: Influenza, TB and MERS-CoV. Carolyn Pim, MD December 10, 2015

WHO Blood Regulators Network (BRN)

Global Connectivity and the Spread of Infectious Diseases

Middle East respiratory syndrome coronavirus (MERS-CoV) and Avian Influenza A (H7N9) update

The mathematics of diseases

Mathematical Modeling of Infectious Disease

Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza

Infectious Disease Epidemiology and Transmission Dynamics. M.bayaty

What is a model and why use one?

Modelling HIV prevention: strengths and limitations of different modelling approaches

The Spanish flu in Denmark 1918: three contrasting approaches

Adjunct Faculty, Division of Epidemiology UC Berkeley School of Public Health. San Francisco Department of Public Health.

Development of Recombinant MERS-CoV Spike (S) Nanoparticle Vaccine

Towards an open-source, unified platform for disease outbreak analysis using

The roadmap. Why do we need mathematical models in infectious diseases. Impact of vaccination: direct and indirect effects

Fig. 2: Total model-predicted influenza-attributable mortality in the presence of differing amounts of seasonal influenza relative to ph1n1.

Public Health Management and Preparedness in Wildlife Zoonotic Disease Outbreak

Surveillance and epidemiology. Natasha S. Crowcroft Director, Surveillance and Epidemiology

EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL?

SURVEILLANCE & EPIDEMIOLOGIC INVESTIGATION NC Department of Health and Human Services, Division of Public Health

2009 (Pandemic) H1N1 Influenza Virus

Department of Defense Armed Forces Health Surveillance Branch Global MERS-CoV Surveillance Summary (14 DEC 2016)

Estimation for the infection curves for the spread of Severe Acute Respiratory. Syndrome (SARS) from a back-calculation approach

NCCID RAPID REVIEW. 1. What are the case definitions and guidelines for surveillance and reporting purposes?

Killer Viruses: The Why and The How. Amesh Adalja

Identifying, Preparing for & Reducing Pandemic Risk

Research Article Perception and Attitude of Emergency Room Resident Physicians toward Middle East Respiratory Syndrome Outbreak

Information collected from influenza surveillance allows public health authorities to:

November 9 to 15, 2014 (week 46)

ARIZONA INFLUENZA SUMMARY Week 1 (1/4/2015 1/10/2015)

8. Public Health Measures

Modelling global epidemics: theory and simulations

Modelling emerging viral threats Raina MacIntyre. School of Public Health and Community Medicine

A Brief History. A Brief History (cont.) February 1, Infectious Disease epidemiology BMTRY 713 (Lecture 7) mathematical Modeling for ID

Influenza & Other Respiratory Viruses Update

Pandemic influenza. Introduction to influenza. Influenza mutation

Confronting infectious diseases and the role of vaccination: A global perspective KATE ANTEYI. MD, MPH, MBA

Comparative epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia and South Korea

Viral Pneumonia: much more than what is diagnosed Filipe Froes

Assessing the Risk of Observing Multiple Generations of Middle East Respiratory Syndrome (MERS) Cases Given an Imported Case

Health care workers and infectious diseases

Digital Disease Detection: MERS, Ebola, and Measles. Maimuna S. Majumder

MISMS: International influenza research activities at the Fogarty International Center, NIH

Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens WORKSHOP ON PRIORITIZATION OF PATHOGENS

Agent-Based Models. Maksudul Alam, Wei Wang

Promoting Public Health Security Addressing Avian Influenza A Viruses and Other Emerging Diseases

Planning for Pandemic Influenza

Department of Defense Armed Forces Health Surveillance Branch Global MERS-CoV Surveillance Summary (11 JAN 2017)

Towards Real Time Epidemic Vigilance through Online Social Networks

Emerging global health threats of animal origin

Transcription:

The Incidence Decay and Exponential Adjustment (IDEA) model: a new single equation model to describe epidemics and their simultaneous control. David N. Fisman, MD MPH FRCP(C) Professor, Dalla Lana School of Public Health, University of Toronto McGill University Department of Epidemiology, Biostatistics and Occupational Health 50 th Anniversary Seminar Series Montreal, PQ October 27, 2014

Outline Single equation models to describe epidemic growth. Richards model (logistic growth). IDEA model. Case studies: MERS and Ebola

What Does Math Have to Do with Infectious Diseases? Communicable diseases: fundamental property is transmission (current cases produce future cases). Contrast with non-communicable diseases (e.g., cancer or diabetes). When current cases produce on average > 1 new case, have an exponential increase in case numbers, a.k.a., an epidemic. Daniel Bernoulli (1700-1782) applies math to smallpox control in Paris. Daniel Bernoulli, Wikimedia Commons (http://en.wikipedia.org/wi ki/file:danielbernoulli.jpg)

Mathematical Models of Infectious Disease Platform for synthesis of best available data, so can: Estimate key parameters (e.g., R 0 ) by fitting models to data. Manage uncertainty related to possible outcomes (but generally not predict the future). Perform stepwise experiments by varying parameters (e.g., identify importance of duration of immunity in pertussis). Platform for realistic CEA.

A Simple Schematic Model of an Infectious Disease ds/dt = -bsi di/dt = +bsi-i/d di/dt = +bsi-i/d-mi dr/dt = I/D S I R m (mortality)

Figure 4. Effect of timing of epidemic peak on preferred vaccination strategy. Tuite AR, Fisman DN, Kwong JC, Greer AL (2010) Optimal Pandemic Influenza Vaccine Allocation Strategies for the Canadian Population. PLoS ONE 5(5): e10520. doi:10.1371/journal.pone.0010520 http://www.plosone.org/article/info:doi/10.1371/journal.pone.0010520

Models in Acute Outbreak Settings Often want to characterize and model disease when novel pathogen emerges: R 0 & serial interval useful for disease control policy. When will it peak? When will it end? How big will it be? What are optimal intervention strategies? Recent examples: SARS, H1N1, MERS, Ebola, chikungunya, EV D68, others. Though lots of missed opportunities (Lloyd Smith, Science 2009).

Low-Hanging Fruit Modeling Human-Animal Interface Lloyd-Smith J. et al., Science 2009

Challenges to Modeling Acute Outbreaks/Emergence Final size formula incorrect (because behavior changes and people intervene). Data hugging, non-transparency. Poor quality data, aggregate data, missing data, reporting delays. Little information on subclinical cases, baseline immunity/cross-immunity (e.g., H1N1). Hard to parameterize compartmental models or ABM without numerous assumptions re: immunity, mixing, biology, etc.

Single Equation Approaches Descriptive rather than mechanistic. Recognize epidemics as stereotyped logistic growth processes (Cum Inc): accelerating growth peak decelerating growth final size.

Single Equation Approaches (2) E.g. Richards model, but many other forms. Provide information on likely final size, turning points, can estimate R 0 via exponnentiation. Scaled in epidemic time (serial intervals) rather than calendar/clock time.

Serial Interval: Measles DAYS 1 SERIAL INTERVAL Case 1 Case 1 Latency Infectious Case 2 Case 2 Latency Infectious

Serial Intervals: Tuberculosis YEARS 1 SERIAL INTERVAL Case 1 Case 1 Latency Infectious Case 2 Case 2 Latency Infectious

Serial Intervals (2) For a given generation (t) and a given R 0 (say, 3) number (n) of incident infections in that generation is: Generation Cases (n t-1 ) Cases (n t ) 0 --- 1 1 1 3 2 3 9 n = R 0 t

Richards Model I (t)=ri[1-(i/k) a ] R 0 = e rt

Estimated impact of aggressive empirical antiviral treatment in containing an outbreak of pandemic influenza H1N1 in an isolated First Nations community Influenza and Other Respiratory Viruses Volume 7, Issue 6, pages 1409-1415, 23 JUL 2013 DOI: 10.1111/irv.12141 http://onlinelibrary.wiley.com/doi/10.1111/irv.12141/full#irv12141-fig-0004

Estimated Reproductive Number 20. 3 1 Richards Model (Respiratory Visits) Richards Model (ILI Visits) SEIR Model (Respiratory Visits) SEIR Model (ILI Visits) Southern Ontario Estimate 7.4 2 2.7 1 10 1 1.5 2 2.5 3 3.5 4 4.5 Serial Interval (Days)

Difficulties with Richards and Other Logistic Models Non-intuitive. Assumptions about exponent of deviation. R 0 estimates seem high?

IDEA Model In the absence of intervention or immunity: I(t) = R 0 t But: intervention occurs, people become immune. Growth decelerates in an accelerating fashion! IDEA Model (Incidence Decay and Exponential Adjustment): I(t) = [R 0 /(1+d) t ] t

Algebraically: IDEA Model (2)

IDEA Model (3) Integrating (eek): where

IDEA Model (4) Evaluated by comparing with outputs of difference (discrete time) SIR model where epidemic is subject to intervention. IDEA agrees well with SIR where intervention efficacy accelerates (first order, RR t ).

Figure 1. Model fits and order of control. Fisman DN, Hauck TS, Tuite AR, Greer AL (2013) An IDEA for Short Term Outbreak Projection: Nearcasting Using the Basic Reproduction Number. PLoS ONE 8(12): e83622. doi:10.1371/journal.pone.0083622 http://www.plosone.org/article/info:doi/10.1371/journal.pone.0083622

Figure 2. IDEA model fits for low R0 epidemics. Fisman DN, Hauck TS, Tuite AR, Greer AL (2013) An IDEA for Short Term Outbreak Projection: Nearcasting Using the Basic Reproduction Number. PLoS ONE 8(12): e83622. doi:10.1371/journal.pone.0083622 http://www.plosone.org/article/info:doi/10.1371/journal.pone.0083622

Figure 3. IDEA model fits for higher R0 epidemics. Fisman DN, Hauck TS, Tuite AR, Greer AL (2013) An IDEA for Short Term Outbreak Projection: Nearcasting Using the Basic Reproduction Number. PLoS ONE 8(12): e83622. doi:10.1371/journal.pone.0083622 http://www.plosone.org/article/info:doi/10.1371/journal.pone.0083622

Figure 5. Pandemic H1N1 case counts modeled with the IDEA Model. Fisman DN, Hauck TS, Tuite AR, Greer AL (2013) An IDEA for Short Term Outbreak Projection: Nearcasting Using the Basic Reproduction Number. PLoS ONE 8(12): e83622. doi:10.1371/journal.pone.0083622 http://www.plosone.org/article/info:doi/10.1371/journal.pone.0083622

MERS Coronavirus Novel coronavirus, identified in Middle East in 2012. Sporadic cases of respiratory illness, retrospective identification of Jordanian hospital outbreak (13 cases). Presumed zoonosis (camels?), foodborne? More transmissible in healthcare setting. Middle Eastern SARS?

Source: http://www.cdc.gov/coronavirus/mers/

Branching Process When R0 < 1, average cluster size (including the index) is: N = 1/(1-R 0 ) Therefore R 0 = -[(1/N)-1]

MERS Co-V, May 2013 http://pandemicinformationnews.blogspot.ca/2013/05/promed-thoughts-ontransmissibility-and.html

Breban et al., Lancet 2013

Fisman, Lipsitch and Leung, Lancet 2014

MERS, Saudi Arabia (June 6, 2014) Healthcare focused outbreaks in Jeddah and Riyadh.

Incident Cases Cumulative Cases 120 100 Observed Incident Cases Observed Cumulative Cases Modeled Cumulative Cases Modeled Incident Cases 600 500 80 400 60 300 40 200 20 100 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Weeks Since March 1, 2014 0

Estimated R0 13 11 9 7 5 3 1 Reported Cases Total Cases Total Cases-Background Total Cases x 2 (50% Under-reporting) 3 5 7 9 11 13 15 Serial Intervals Utilized

Estimated d 1 0.8 0.6 0.4 0.2 (Figures 3a and 3b) Reported Cases Total Cases Total Cases-Background Total Cases x 2 (50% Under-reporting) 0 3 5 7 9 11 13 15 Serial Intervals Utilized

Incident Cases 120 100 80 60 40 20 0 0 5 10 15 Generation/Weeks Since March 1, 2014 Model (4 week fit) Model (6 week fit) Model (7 week fit) Model (8 week fit) Model (10 week fit) Model (12 week fit) Total Observed Cases

APPLICATION TO EBOLA, 2014 [PLOS CURRENTS OUTBREAKS, SEPTEMBER 8, 2014]

Model Fitting Used WHO time series (cumulative cases, cumulative deaths) available at http://virologydownunder.blogspot.com.au and https://github.com/cmrivers/ebola (Ian Mackay and Caitlin Rivers). Publication based on cases to August 22, 2014. Collapsed by generation, base case used data aggregated across Liberia, SL, Guinea. Assume initial recognition occurred in generation 5 (back estimated based on 40-80 cases in March 2014, with previously reported R0 ~ 1.5 or 2).

R 0 and d, by Generation [Source: Fisman et al, Plos Currents Outbreaks 2014]

Best-fit Parameters [Source: Fisman et al, Plos Currents Outbreaks 2014]

[Source: Fisman et al, Plos Currents Outbreaks 2014]

[Source: Fisman et al, Plos Currents Outbreaks 2014]

Projection, and Effect of Intervention (d = 0.014) [Source: Fisman et al, Plos Currents Outbreaks 2014]

Projections, October 2014

Hypothetical Vaccine (Re = 0.9)

Summary Modeling emerging pathogens in outbreak settings may provide important information for disease control. Publicly available data sources, aggregate data can still be utilized to identify plausible ranges of disease parameters. May be able to identify peak in near-real time with IDEA (though hard to project).

Summary (Ebola) IDEA appears to describe and predict Ebola epidemic behavior reasonably well. Fairly robust with varying assumptions about serial interval, start date, undercounting. Should identify shift in epidemic dynamics if one occurs (not seeing that with Ebola). Simple (can do this in a spreadsheet). Seems intuitive (per students). Use in the field?